Literature DB >> 8039809

Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production.

J H Martin1, S W Edwards.   

Abstract

Interferon-gamma (IFN-gamma) enhanced the cytotoxic capability of freshly isolated human blood monocytes but failed to enhance the tumoricidal competence of monocyte-derived macrophages. Treatment of monocytes with IFN-gamma (100 U/ml) caused a significant increase (P < 0.001) in lucigenin-dependent chemiluminescence and O2- production stimulated by N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) during the first few days in culture but IFN-gamma was unable to prevent the decline to negligible levels of chemiluminescence and O2- production which occurred during the later days in vitro. Culture of monocytes in the presence of IFN-gamma had no effect on phorbol 12-myristate 13-acetate (PMA)-stimulated O2- production. However, IFN-gamma decreased PMA-stimulated lucigenin-dependent chemiluminescence during the first 24 hr in vitro but then significantly enhanced (P < 0.001) chemiluminescence after 2-4 days in culture. IFN-gamma was unable to prevent the eventual decline to undetectable levels in PMA-stimulated chemiluminescence during the later days in vitro. Nitrite production by macrophages was unaffected by IFN-gamma treatment. It is concluded therefore, that IFN-gamma enhanced the cytotoxicity of freshly isolated human blood monocytes by increasing reactive oxygen intermediate generation but was unable to enhance the tumoricidal competence of macrophages as reactive nitrogen intermediate production was unaffected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039809      PMCID: PMC1422376     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

2.  Influence of interferon on human monocyte to macrophage development.

Authors:  S Becker
Journal:  Cell Immunol       Date:  1984-03       Impact factor: 4.868

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Pre-exposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity.

Authors:  A Severn; D Xu; J Doyle; L M Leal; C A O'Donnell; S J Brett; D W Moss; F Y Liew
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

5.  Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

Authors:  J Le; W Prensky; Y K Yip; Z Chang; T Hoffman; H C Stevenson; I Balazs; J R Sadlik; J Vilcek
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

6.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.

Authors:  P M Guyre; P M Morganelli; R Miller
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.

Authors:  D G Fischer; M G Golightly; H S Koren
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

8.  Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages.

Authors:  N Sakai; S Milstien
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

9.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Authors:  F Herrmann; S A Cannistra; H Levine; J D Griffin
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

10.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma.

Authors:  C F Nathan; T J Prendergast; M E Wiebe; E R Stanley; E Platzer; H G Remold; K Welte; B Y Rubin; H W Murray
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  5 in total

1.  Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.

Authors:  A Trulson; S Nilsson; P Venge
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

2.  The contributions of reactive oxygen intermediates and reactive nitrogen intermediates to listericidal mechanisms differ in macrophages activated pre- and postinfection.

Authors:  S Ohya; Y Tanabe; M Makino; T Nomura; H Xiong; M Arakawa; M Mitsuyama
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Immunomodulatory effects of polar lichens on the function of macrophages in vitro.

Authors:  Hye-Sook Choi; Joung Han Yim; Hong Kum Lee; Suhkneung Pyo
Journal:  Mar Biotechnol (NY)       Date:  2008-07-09       Impact factor: 3.619

Review 4.  Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review.

Authors:  J B Weinberg
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

5.  A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections.

Authors:  Matthias Eberl; Gareth W Roberts; Simone Meuter; John D Williams; Nicholas Topley; Bernhard Moser
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.